BPC 157 reduces immediate and delayed damage induced brain trauma and improves nerve regeneration after transection
That tiny amount of benzyl alcohol acts as a bacteriostatic agent, meaning it prevents bacteria from growing and reproducing in the solution
Aleniglipron Shows Promising Weight Loss Results in Phase 2 Trial Oral GLP-1 Drug Shows Promising Weight Loss Results in Phase 2 Trial Patients on the highest aleniglipron dose achieved up to 12% weight loss at 36 weeks A new strategy for delivering GLP-1 drugs to patients with obesity or who were overweight resulted in up to a 12 percent reduction in body weight after 36 weeks, according to a randomized phase II clinical trial published in Nature Medicine
However, even severe PCO may not be considered clinically relevant if it is present in a patient whose vision is already impaired for other reasons such as age-related macular degeneration or glaucoma (103, 104)
The result is a drug that reduces how much you eat, improves how your body processes sugar, and increases how many calories your body burns, all at once
Naunyn-Schmiedeberg's Arch Pharmacol 398 , 351362 (2025)